Single-Use Systems in the Fill Finish Manufacturing Industry

 

Single-use systems (SUS), often known as disposable technology, can improve manufacturing productivity by eliminating the time needed for cleaning and validations. Furthermore, employing SUS lowers the expense of cleaning.

Single-use technology can solve some of the issues that have plagued the fill finish stage of the pharmaceutical production process for a long time. Single-use and disposable equipment According to the majority of experts we polled, adoption is the most crucial trend in fill and finish today.

However, some benefits are accrued to using single-use systems in the pharmaceutical world.

Benefits of Using Single-Use for Fill Finish in the Pharmaceutical Industry

Several pharmaceutical fill finish manufacturing processes ahead of this stage are increasingly shifting toward single-use solutions to improve operational flexibility, minimize contamination risk and capital expenditure, and remove cleaning while boosting operator safety. Reduced contamination risk, reduced authentication and operation time, and enhanced safety, productivity, and expenditures are potential benefits of single-use systems.

Cross-contamination from equipment is entirely eliminated when single-use systems are used. It can reduce the cost of getting a customer's product into production by removing the need to purchase expensive steel tanks and other items with long lead periods. With any strategy, there are still trade-offs, but single-use is becoming more appealing.

Since no cleaning method must be developed and aseptic fill finish connections are easy to make, single-use equipment is faster and safer in terms of contamination and aseptic handling than conventional equipment. However, there is a chance that the product contact material and the bulk medicine substance will interact.

As a result, a leachable and extractable assessment is required. Because no cleaning method must be developed and aseptic connections are easy to make, single-use equipment is faster and safer in terms of contamination and aseptic handling than conventional equipment. However, there is a chance that the product contact material and the bulk medicine substance will interact. As a result, a leachable assessment is required.

Single-use assemblies, such as those for pharmaceutical fill-finish, are a viable choice for new and existing plants. Single-use machinery is making its way into many unit operations, allowing many contract manufacturing companies to be more flexible.

On the other hand, single-use technologies have an advantage over stainless systems regarding contamination management. Most respondents in the PharmTech poll said that single-use systems have a lower risk of contamination. Because a single-use filling line has fewer connection points than a fixed-pipe line, the risk of microbial contamination is reduced.

Suppose you can logically address the risks, these present benefits and possibilities to improve flexibility. Examine single-use options; it might be the answer your facility is looking for.

Conclusion

In fill-finish operations, single-use solutions can be a huge help because they can:

● Reduce the number of manual connections and processes

● Improve capacity management by making changeovers faster

● Improve the management of contaminated hazardous components, and

●Increase facility capacity without additional autoclaves or water for injection (WFI) generation.

For more information about our pharmaceutical manufacturing services, contact us at abbvie contract manufacturing.